A two-week course of high doses of CBD helps restore the function of two proteins key to reducing the accumulation of beta-amyloid plaque, a hallmark of Alzheimer’s disease, and improves cognition in an experimental model of early onset familial Alzheimer’s, investigators report.

The proteins TREM2 and IL-33 are important to the ability of the brain’s immune cells to literally consume dead cells and other debris like the beta-amyloid plaque that piles up in patients’ brains, and levels of both are decreased in Alzheimer’s.

The investigators report for the first time that CBD normalizes levels and function, improving cognition as it also reduces levels of the immune protein IL-6, which is associated with the high inflammation levels found in Alzheimer’s, says Dr. Babak Baban, immunologist and associate dean for research in the Dental College of Georgia and the study’s corresponding author.

Click Here to read the rest of the article in the Augusta University Jagwire.

Now is the time to be a leader in the CBD industry. Get Certified!

WE DO NOT PROVIDE MEDICAL ADVICE.

Any Information Accessed Through This Blog/Site Is Not Intended To Be A Substitute For Medical Advice, Diagnosis, Or Treatment And Not Intended To Cover All Possible Uses, Directions, Precautions, Or Adverse Effects. Please Consult Your Healthcare Professional About Potential Interactions Or Other Possible Complications Before Using Any Product That Is Mentioned On This Site.